Narrow Results

This study was carried out to assess the effect of bone marrow transplant into the 47 ununited fracture sites of the long bones of the extremities in 46 patients on bone healing. Among 46 cases, there were 43 pure fractures; a case of simultaneous ipsilateral femoral and tibial osteotomies for leg lengthening; a case of ununited repositioned cryo-treated proximal half of tibia as a limb salvage; and a case of internal transport of proximal tibia.

Among the 43 pure fractures, there were 11 hypertrophic, 30 oligotrophic, and 2 gap nonunions. Bone marrow transplant was performed for any type of the delayed union and nonunion, and was also indicated in the distraction callotasis site of poor osteogenesis.

Overall union rate in 43 fractures was 55.8% (24 cases). In two gap nonunions, no callus was formed. Union was obtained in all the 11 hypertrophic nonunions and 13 (46.4%) of the 30 oligotrophic nonunions. The oligotrophic and gap nonunions responded poorly to the marrow transplant. One of the two tibial osteotomy gaps healed with good evidence of endosteal callus formation. In a femoral osteotomy site for lengthening and in an ununited repositioned site of the cryo-treated tibia, there were no visible callus at all. The average time for clinical and radiological unions in the fracture cases were 5 and 7 months on average. In our series, there were no complications, including infection.

The results in this series suggest that bone marrow transplant is a good source of callus formation or stimulant in treating the delayed union and hyper- and oligotrophic nonunions of any origin, and also enhances the callus formation at the gap of the early stage of the internal transport.

AUSTRALIA – Australian Scientists Make Breakthrough on HIV's Infectious Grip.

AUSTRALIA – Australian Researchers Developing New Dengue Vaccine.

AUSTRALIA – Heart Attack Genes Discovered.

AUSTRALIA – Australian Researchers Find Blindness Genes.

AUSTRALIA – Innovative Spinal Surgery Performed at Austin Health.

AUSTRALIA – Future Risks for Child Cancer Survivors Seven Times Higher.

AUSTRALIA – Triggers Found on Asthma Risk.

AUSTRALIA – One-dose Malaria Killer Drug.

BANGLADESH – 589 People Confirmed to be infected by Anthrax in Bangladesh.

CHINA – Banned Chemical Found in China Cosmetics.

CHINA – China PharmaHub Corp. Introduces A 'Magic Bullet' Liver Cancer Therapy.

INDIA – BARC Develops Radionuclides for Inoperable Cancers, Arthritis.

INDIA – Vaccine Makers to Lobby for Higher Immunization Coverage.

SINGAPORE – Singapore and Seattle Eye Banks Collaborate to Increase World Supply of Tissue for Sight-Restoring Corneal Transplants.

SINGAPORE – Doctors Discover Tamiflu-Resistant H1N1 Superbug.

SINGAPORE – P&G Partners A*STAR to Strengthen R&D Presence in Singapore.

SINGAPORE – NCCS-led Study Helps Doctors to Better Identify Treatment for Colorectal Cancer Patients.

OTHER REGIONS — EUROPE – Gene Therapy Success for Anemia Patient.

OTHER REGIONS — NORTH AMERICA – Researchers Find Genes Linked to Ovarian Cancer.

AUSTRALIA – Australia Lifts Transplant Rate.

AUSTRALIA – Tamarind Derivative Repairs Damaged Brain Cells.

AUSTRALIA – High Hopes for Ross River Virus Vaccine.

AUSTRALIA – Genetic Link to Risk of Developing Bone Disease.

AUSTRALIA – Edible Vaccine in the Works.

CHINA – China Mulls New Mental Health Law.

CHINA – University of Pennsylvania Pairs up with Chinese Academy of Sciences for Neuroimaging.

INDIA – Vaccine Tests for Brain Virus.

KOREA – New Technique Makes Artificial Bones More Natural.

KOREA – Scientists Develop Magnetic Nanoparticles that Kill Cancer Cells.

SINGAPORE – IE Singapore Forms Biomedical R&D Consortium.

VIETNAM – Fatty Liver Disease on the Rise Among Youth.

OTHER REGIONS — New Clues to How Cancer Spreads.

OTHER REGIONS — Scientists Find Genes Linked to Migraines.

OTHER REGIONS — New Drug Makes Hearts Repair Themselves.

AUSTRALIA – HIV trial validates novel drug mechanism.

SINGAPORE – IBN engineered artificial human livers for drug testing and discovery.

SINGAPORE – Scientists at A*STAR's Genome Institute of Singapore catch evolving germs and cancer cells early.

SINGAPORE – DocDoc and Chatter Buzz Media enter strategic partnership to launch Asia's first healthcare Content Marketing Network.

UNITED STATES – New method developed to expand blood stem cells for bone marrow transplant.

UNITED STATES – Fibrocell/UCLA study on human skin cells yields promising results.

UNITED STATES – Metal stents are effective treatment for blocked bile ducts.

UNITED STATES – Pain drug may prevent preemie lung damage.

UNITED STATES – Gene x3 helps corn grow in acidic soil.

UNITED STATES – Cancer Genetics selected by Gilead Sciences, Inc. to provide clinical trial services for chronic lymphocytic leukemia.

UNITED KINGDOM – DaTSCAN™ SPECT imaging demonstrates impact on the diagnosis of patients with clinically uncertain dementia.

AFRICA – Failing vaccine strategies need to be revamped.

AFRICA – RegeneCure's membrane implant shows 40% accelerated healing time of severe bone fractures.

The clinical need for an alternative to donor corneal tissue has encouraged much interest in recent years. An artificial cornea whether it be bio-engineered or a synthetic keratoprosthesis must fulfill the functions of the cornea it replaces: transparent, refractive surface, protection, non-immunogenic. A wide range of implants and biomedical devices have been developed in an attempt to correct corneal blindness. Limitation of existing biomaterials are evident when reviewing keratoprosthesis surgery complications. These include infection, intraocular inflammation, retromembrane formation, inadequate interface seal thus epithelial downgrowth and glaucoma. Attempts to improve healing in such cases have involved using various polymers or tissues to surround the optic. The successes and failures of synthetic prostheses that have been implanted in humans is discussed. More recently, the idea of a bio-engineered cornea has arisen. Tissue-engineering involves the manipulation of cells using in vitro techniques to create a composite tissue, which could then be implanted in vivo. Corneal equivalents have been reconstructed from corneal cell lines. They already have their potential uses in the biomedical world: as replacements for animals in toxicology testing and pharmacological studies, as well as in basic research into cell-cell and cell-matrix interactions of corneal wound healing. Current research is ongoing to determine if the bio-engineered cornea will have a role in corneal transplant surgery.